Date Filed | Type | Description |
06/12/2023 |
4
| McHugh Julie (Director) has filed a Form 4 on Evelo Biosciences, Inc.
Txns:
| Granted 20,000 options to buy
@ $0.11, valued at
$2.2k
|
|
05/15/2023 |
4
| McHugh Julie (Director) has filed a Form 4 on Lantheus Holdings, Inc.
Txns:
| Granted 2,012 shares
@ $0 Granted 3,798 options to buy
@ $99.38, valued at
$377.4k
|
|
11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/08/2022 |
4
| McHugh Julie (Director) has filed a Form 4 on Lantheus Holdings, Inc.
Txns:
| Sold 4,300 shares
@ $78.5, valued at
$337.6k
|
|
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2022 |
4
| McHugh Julie (Director) has filed a Form 4 on Evelo Biosciences, Inc.
Txns:
| Granted 20,000 options to buy
@ $2.6, valued at
$52k
|
|
06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2022 |
4
| McHugh Julie (Director) has filed a Form 4 on Lantheus Holdings, Inc.
Txns:
| Sold 2,980 shares
@ $57.84, valued at
$172.4k
|
|
05/12/2022 |
4/A
| McHugh Julie (Director) has filed a Form 4 on Lantheus Holdings, Inc.
Txns:
| Granted 4,068 options to buy
@ $64.2, valued at
$261.2k
|
|
05/10/2022 |
4
| McHugh Julie (Director) has filed a Form 4 on Lantheus Holdings, Inc.
Txns:
| Granted 2,180 shares
@ $0 Granted 3,616 options to buy
@ $64.2, valued at
$232.1k
|
|
03/16/2022 |
4
| McHugh Julie (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Sold 20,000 shares
@ $11.67, valued at
$233.4k
|
|
12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/09/2020 |
4
| McHugh Julie (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Sold 7,950 shares
@ $9.77, valued at
$77.7k
|
|
08/12/2020 |
4
| McHugh Julie (Director) has filed a Form 4 on Lantheus Holdings, Inc.
Txns:
| Granted 749 shares
@ $0 |
|
06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/05/2020 |
4
| McHugh Julie (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Granted 21,720 shares
@ $0 |
|
05/15/2020 |
4
| McHugh Julie (Director) has filed a Form 4 on TREVENA INC
Txns:
| Granted 64,103 options to buy
@ $1.05, valued at
$67.3k
|
|
03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/07/2019 |
4
| McHugh Julie (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Sold 1,500 shares
@ $11.26, valued at
$16.9k
|
|
05/31/2019 |
4
| McHugh Julie (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Granted 22,706 shares
@ $0 |
|
05/23/2019 |
4
| McHugh Julie (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Granted 1,750 shares
@ $0 Granted 7,800 options to buy
@ $39.44, valued at
$307.6k
|
|
05/16/2019 |
4
| McHugh Julie (Director) has filed a Form 4 on TREVENA INC
Txns:
| Granted 30,000 options to buy
@ $1.34, valued at
$40.2k
|
|
03/08/2019 |
4
| McHugh Julie (Director) has filed a Form 4 on Lantheus Holdings, Inc.
Txns:
| Sold 2,595 shares
@ $22.765, valued at
$59.1k
|
|
03/06/2019 |
4
| McHugh Julie (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Sold 1,500 shares
@ $14.38, valued at
$21.6k
|
|
02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|